← FDA Drug Approvals (Drugs@FDA)
SODIUM NITROPRUSSIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BE PHARMS · Approved 2021-07-12
Drug application
- FDA Application #
ANDA214971- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SODIUM NITROPRUSSIDE
- Generic name
- SODIUM NITROPRUSSIDE
- Active ingredients
- SODIUM NITROPRUSSIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- BE PHARMS
- Manufacturer
- BE Pharmaceuticals Inc.
- First approval
- 2021-07-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown